NCT04789304View on ClinicalTrials.gov

A Study to Test How Healthy Men Tolerate Different Doses of BI 1595043

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

January 14, 2022

Study Completion Date

January 14, 2022

Conditions
Healthy
Interventions
DRUG

BI 1595043

BI 1595043

DRUG

Placebo

Placebo

DRUG

Midazolam

Midazolam

Trial Locations (1)

2650

SGS Life Science Services - Clinical Research, Edegem

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04789304 - A Study to Test How Healthy Men Tolerate Different Doses of BI 1595043 | Biotech Hunter | Biotech Hunter